Archive for February, 2009

Cytogenix Labs’ NEW Xenadrine RFA-1™: Clinical Strength Weight Loss?

Xenadrine, quite frankly, is one of the most recognizable fat burner brand names in history (only Muscle Tech's Hydroxycut supercedes it, in my opinion). It has taken several forms over the last several years—the original ephedra-based Xenadrine RFA-1, and the ephedra-free Xenadrine EFX.

Comments off

Doctors win ICD-10 coding reprieve; compliance now due by 2013

The Bush administration also finalizes no-pay rules for surgical errors and prepares to bring back DME competitive bidding.

Comments off

“Inevitable” Blues merger implodes at 11th hour

Pennsylvania's Highmark Inc. and Independence Blue Cross scrap a deal rather than agree to state regulators' conditions. This could signal greater scrutiny for mergers nationwide.

Comments off

FTC finds price-fixing at physician IPAs, suggests legal alternatives

Experts warn of antitrust scrutiny but say the settlements signal the FTC's support of arrangements that can benefit patient care.

Comments off

Analysis compares competing health system reform plans

Some proposals would cover nearly everyone who is uninsured, say researchers from the Commonwealth Fund.

Comments off

« Previous entries ·